The FDA recently approved three new drugs for the treatment of type 2 diabetes, all featuring the new SGLT-2 inhibitor, ertugliflozin. The first, Steglatro, is ertugliflozin available in 5-mg and 15-mg tablets, approved for adults with type 2 as an adjunct to diet and exercise to improve glycemic control. The second, Steglujan, is a tablet […]
People with diabetes or prediabetes can be at much greater risk of frostbite during the cold winter months, due to complications like neuropathy and poor circulation.The risk was dramatically illustrated a few years ago by the experience of British explorer Sir Ranulph Fiennes, who had to pull out of a grueling expedition to cross Antarctica […]
The links between menopause and diabetes aren’t fully understood, but there are some definite ways in which they can interact. It’s possible that the hormonal shifts of menopause may increase the risk of developing type 2. For women who already have diabetes, blood sugar highs and lows can be related to fluctuations in estrogen and […]
GLP-1 agonists are a class of drugs that are widely used to treat type 2 diabetes. Drugs of this type have been shown to improve glycemic control and also to decrease systolic blood pressure, decrease triglycerides, increase sodium excretion, and promote weight loss. Exenatide is a popular GLP-1 agonist that has been used for over […]
Researchers have found that a protein associated with anxiety and depression may also contribute to the development of type 2 diabetes. The protein, FKBP51, plays a part in the regulation of the stress system. A mutation in the gene that controls the production of FKBP51 can lead to a dysregulation of the stress system. This […]
A new study found that socially isolated people were more likely to be diagnosed with type 2 diabetes than people with larger social networks. The risk is highest for men living alone. The researchers suggest that people at risk of type 2 should take steps to increase their social networks, such as joining clubs or […]
New recommendations in the 2018 edition of the American Diabetes Association’s (ADA’s) Standards of Medical Care in Diabetes include advances in cardiovascular disease risk management, including hypertension; an updated care algorithm that is patient-focused; the integration of new technology into diabetes management; and routine screening for type 2 diabetes in high-risk youth. They also provide […]
Diabetic peripheral neuropathy (DPN) can affect patients with both type 1 and type 2 diabetes. It often affects the legs and feet, causing pain, numbness, and tingling. It can also affect the digestive system, urinary tract, blood vessels and heart. It affects over a quarter of adults newly diagnosed with diabetes, but it has not […]
Type 2 diabetes is caused by the failure of beta cells in the pancreatic islets to deliver enough insulin to maintain blood glucose levels in normal ranges. Researchers recently identified a novel cluster of dysregulated genes in the pancreatic islets of patients with type 2 diabetes. The researchers sought to identify which genes are abnormally […]
Vitamin D deficiency is common in children and teenagers with type 1 diabetes. Researchers have found that supplementation with cholecalciferol (Vitamin D3) to bring Vitamin D to normal levels in children who were deficient also benefited their blood glucose control. The children with the highest blood glucose levels before the supplementation showed the greatest improvement. Read […]
A new study published in the journal Cancer links type 2 diabetes to a greater risk of breast cancer in African-American women. The study looked at whether diabetes may be linked to certain breast cancer subtypes. The study followed nearly 55,000 women participating in the Black Women’s Health study, for eighteen years. The researchers found […]
The results of a coronary artery calcium (CAC) score can better predict heart attack and stroke risk in patients with type 2 than traditional tests, according to new research. The researchers found that people with coronary calcium scores of 100 or higher were at two to three times greater risk than those with no calcium […]
A new study has found that participants who consumed high amounts of magnesium, either through diet or through supplementation, had a reduced risk of developing type 2 diabetes. The patients who benefitted most from magnesium supplementation were those whose overall diets were poor; the added magnesium resulted in greater reduction in risk for these patients. […]
People living with psoriasis have a greater risk of developing type 2 diabetes, and those whose psoriasis is severe are at greatest risk, according to new research. A new study from the University of Pennsylvania Perelman School of Medicine in Philadelphia found that the risk of diabetes rises in psoriasis patients according to the severity […]
Eating a diet that is rich in antioxidant foods can help reduce your type 2 diabetes risk, according to new research. There’s been previous research that has suggested oxidative stress — cumulative damage done by free radicals that haven’t been neutralized by antioxidants — might contribute to the development of type 2 diabetes. Fruits, vegetables, […]
Cognitive issues can be a complication of type 2 diabetes. This is because diabetes affects blood circulation, and impaired blood flow to the brain can have a negative affect on people’s ability to think and make decisions. A 10-year-long study examined whether participants with type 2 diabetes who lowered calories in their diet and increased […]
Insulin resistance, which occurs when the body’s cells are no longer able to respond to insulin, is a major risk factor for developing type 2 diabetes. For people with insulin resistance, blood glucose levels can become too high, which over time can contribute to the development of type 2. Currently, medications such as thiazolidinediones are […]
A new study suggests that U.S. diabetes cases that go undiagnosed may be just 11%, or just over one tenth of people with diabetes. This is much lower than the previously accepted estimates, which concluded one quarter to one third of people with diabetes went undiagnosed. The proportion of undiagnosed cases has also been declining […]
Boehringer and Eli Lilly and Co. are working together to develop a risk model using anonymized patient data. The model will predict how likely patients are to develop three health issues associated with type 2 diabetes: cardiovascular death, kidney failure and hospitalization for heart failure. The goal is to create a model that will help […]
Sanofi and Innovation Health (an insurance company run by Inova and Aetna) are collaborating on a pilot program that will look at how digital health strategies can improve care for patients with type 2 diabetes. The program will use the diabetes self-management app One Drop along with Gocap, an insulin dose management platform that emphasizes […]